NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitamin A and D | LANOLIN, PETROLATUM | Trifecta Pharmaceuticals USA LLC | 453dffec-de9d-0eac-e054-00144ff8d46c | 2024-12-20 | Warnings | 4T6H12BN9U |
| Vitamin A and D | LANOLIN, PETROLATUM | Trifecta Pharmaceuticals USA LLC | 455a16fd-9ce5-6bef-e054-00144ff88e88 | 2024-12-20 | Warnings | 4T6H12BN9U |
| Tripleantibioticointmentandpainrelief | FAMILY WELLNESS BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINE | Trifecta Pharmaceutical USA LLC | 91575333-5268-5d8f-e053-2a95a90a7a89 | 2024-12-20 | Warnings | M004 |
| White Petrolatum | PETROLATUM | Trifecta Pharmaceuticals USA LLC | f1eb0ec2-98e7-13a2-e053-2a95a90a2938 | 2024-12-20 | Warnings | 4T6H12BN9U |
| Premier Value Max Strength Antibiotic plus pain relief | PREMIER VALUE NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCL | Pharmacy Value Alliance LLC | 9767821e-054b-3bd3-e053-2a95a90a4b0e | 2024-12-20 | Warnings | M004 |
| Premier Value Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Premier Value Alliance LLC. | ab843664-a1e0-6716-e053-2995a90a2063 | 2024-12-20 | Warnings | M004 89Y4M234ES |
| Premier Value Bacitracin Zinc | BACITRACIN ZINC | Pharmacy Value Alliance LLC | 99d789be-aa85-0917-e053-2a95a90acd13 | 2024-12-20 | Warnings | M004 1366116 89Y4M234ES |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Pharmacy Value Alliance, LLC | 3803a61b-308a-14a9-e054-00144ff88e88 | 2024-12-20 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Premier Value Alliance LLC. | ab863d90-1a8f-3c1f-e053-2a95a90aa0a7 | 2024-12-20 | Warnings | M004 89Y4M234ES |
| White Rain Original Petroleum | WHITE PETROLEUM | INTERNATIONAL WHOLESALE INC. | d6ebe00c-b692-5171-e053-2a95a90a976c | 2024-12-19 | Warnings | 4T6H12BN9U |
| Health Smart Original Petroleum | WHITE PETROLEUM | Home Smart Products | aedf746f-4c49-421d-a666-1ba02e8fb17d | 2024-12-19 | Warnings | 4T6H12BN9U |
| white rain Cocoa Butter Petroleum Jelly | WHITE PETROLATUM | INTERNATIONAL WHOLESALE INC. | d7068e2b-c3b2-d16d-e053-2a95a90a6dd2 | 2024-12-19 | Warnings | 4T6H12BN9U |
| Health Smart Lavender Baby Petroleum | WHITE PETROLEUM | Home Smart Products | 5828df37-2a42-4129-8e4e-d5ac9c4c9615 | 2024-12-19 | Warnings | 4T6H12BN9U |
| Petroleum Jelly | WHITE PETROLATUM | Rejoice International Inc. | 980d030a-feaf-4a81-865e-f85c66151380 | 2024-12-19 | Warnings | 4T6H12BN9U |
| Baby Petroleum Jelly | WHITE PETROLATUM | Rejoice International Inc. | caf568aa-3889-41ff-835e-875bb6d9ca79 | 2024-12-19 | Warnings | 4T6H12BN9U |
| Petroleum Jelly | WHITE PETROLATUM | Rejoice International Inc. | a45eb8aa-9fc9-4332-a3ef-0e6fd348fb95 | 2024-12-19 | Warnings | 4T6H12BN9U |
| Cars Petroleum | WHITE PETROLATUM | Ultra Distributors Inc. | 9905b5a4-382e-4d2a-b971-37998c14c330 | 2024-12-19 | Warnings | 4T6H12BN9U |
| Health Smart Aloe Vera Petroleum | WHITE PETROLEUM | Home Smart Products | 2671f2ed-af9d-4234-95bf-def368242a78 | 2024-12-19 | Warnings | 4T6H12BN9U |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | 4T6H12BN9U |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | 4T6H12BN9U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.